nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—CNR1—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.0284	0.237	CbGpPWpGaD
Nabilone—Dronabinol—ABCB1—peripheral nervous system neoplasm	0.011	1	CrCbGaD
Nabilone—CNR1—N-cadherin signaling events—PTPN11—peripheral nervous system neoplasm	0.00512	0.0427	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00424	0.0353	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.00382	0.0319	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00332	0.0277	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	0.00325	0.0271	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00323	0.0269	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00309	0.0258	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.00265	0.0221	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00253	0.0211	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00243	0.0202	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.00243	0.0202	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00239	0.02	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00209	0.0175	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.0019	0.0159	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00188	0.0157	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00182	0.0152	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00169	0.0141	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00166	0.0138	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00164	0.0137	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00159	0.0132	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00149	0.0125	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00145	0.0121	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00143	0.0119	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00138	0.0115	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.0013	0.0108	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00127	0.0106	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00125	0.0105	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00125	0.0104	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.00121	0.0101	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00116	0.00966	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00114	0.00949	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00108	0.00905	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000995	0.0083	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000984	0.00821	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000978	0.00816	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000938	0.00782	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000909	0.00758	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000819	0.00683	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000767	0.0064	CbGpPWpGaD
Nabilone—Infection—Cisplatin—peripheral nervous system neoplasm	0.000751	0.000864	CcSEcCtD
Nabilone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00075	0.000863	CcSEcCtD
Nabilone—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000748	0.000861	CcSEcCtD
Nabilone—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000746	0.000858	CcSEcCtD
Nabilone—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000746	0.000858	CcSEcCtD
Nabilone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000744	0.000856	CcSEcCtD
Nabilone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000744	0.000856	CcSEcCtD
Nabilone—Rash—Topotecan—peripheral nervous system neoplasm	0.000744	0.000856	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000744	0.00621	CbGpPWpGaD
Nabilone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000743	0.000855	CcSEcCtD
Nabilone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000743	0.000855	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000743	0.0062	CbGpPWpGaD
Nabilone—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000743	0.000854	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000741	0.00618	CbGpPWpGaD
Nabilone—Cough—Etoposide—peripheral nervous system neoplasm	0.00074	0.000852	CcSEcCtD
Nabilone—Headache—Topotecan—peripheral nervous system neoplasm	0.000739	0.00085	CcSEcCtD
Nabilone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000738	0.000849	CcSEcCtD
Nabilone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000738	0.000849	CcSEcCtD
Nabilone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000738	0.000849	CcSEcCtD
Nabilone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000737	0.000848	CcSEcCtD
Nabilone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000737	0.000848	CcSEcCtD
Nabilone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000737	0.000848	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000736	0.00614	CbGpPWpGaD
Nabilone—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000735	0.000846	CcSEcCtD
Nabilone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000735	0.000845	CcSEcCtD
Nabilone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000733	0.000844	CcSEcCtD
Nabilone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000733	0.000844	CcSEcCtD
Nabilone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000733	0.000843	CcSEcCtD
Nabilone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000731	0.000841	CcSEcCtD
Nabilone—Constipation—Vincristine—peripheral nervous system neoplasm	0.000731	0.000841	CcSEcCtD
Nabilone—Pain—Vincristine—peripheral nervous system neoplasm	0.000731	0.000841	CcSEcCtD
Nabilone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000731	0.000841	CcSEcCtD
Nabilone—Rash—Melphalan—peripheral nervous system neoplasm	0.000728	0.000838	CcSEcCtD
Nabilone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000728	0.000837	CcSEcCtD
Nabilone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000725	0.000835	CcSEcCtD
Nabilone—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000722	0.000831	CcSEcCtD
Nabilone—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000721	0.00083	CcSEcCtD
Nabilone—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00072	0.000829	CcSEcCtD
Nabilone—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000719	0.000828	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000716	0.00598	CbGpPWpGaD
Nabilone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000714	0.000821	CcSEcCtD
Nabilone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000706	0.000813	CcSEcCtD
Nabilone—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000705	0.000812	CcSEcCtD
Nabilone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000705	0.000811	CcSEcCtD
Nabilone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000701	0.000807	CcSEcCtD
Nabilone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000701	0.000807	CcSEcCtD
Nabilone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000701	0.000806	CcSEcCtD
Nabilone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000699	0.000804	CcSEcCtD
Nabilone—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000699	0.000804	CcSEcCtD
Nabilone—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000698	0.000803	CcSEcCtD
Nabilone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000695	0.0008	CcSEcCtD
Nabilone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000695	0.0008	CcSEcCtD
Nabilone—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000692	0.000796	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000689	0.000792	CcSEcCtD
Nabilone—Infection—Etoposide—peripheral nervous system neoplasm	0.000688	0.000791	CcSEcCtD
Nabilone—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000687	0.000791	CcSEcCtD
Nabilone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000686	0.00079	CcSEcCtD
Nabilone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000686	0.00079	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000684	0.00571	CbGpPWpGaD
Nabilone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000679	0.000781	CcSEcCtD
Nabilone—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000676	0.000778	CcSEcCtD
Nabilone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000676	0.000777	CcSEcCtD
Nabilone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000676	0.000777	CcSEcCtD
Nabilone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000674	0.000775	CcSEcCtD
Nabilone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000669	0.00077	CcSEcCtD
Nabilone—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.000768	CcSEcCtD
Nabilone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00066	0.000759	CcSEcCtD
Nabilone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000657	0.000756	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000656	0.00547	CbGpPWpGaD
Nabilone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000655	0.000753	CcSEcCtD
Nabilone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.000752	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00065	0.00543	CbGpPWpGaD
Nabilone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000647	0.000744	CcSEcCtD
Nabilone—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000647	0.000744	CcSEcCtD
Nabilone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000646	0.000744	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000643	0.00536	CbGpPWpGaD
Nabilone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000636	0.000732	CcSEcCtD
Nabilone—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000631	0.000725	CcSEcCtD
Nabilone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00063	0.000725	CcSEcCtD
Nabilone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000628	0.000722	CcSEcCtD
Nabilone—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000623	0.000717	CcSEcCtD
Nabilone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000623	0.000717	CcSEcCtD
Nabilone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000622	0.000715	CcSEcCtD
Nabilone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000617	0.00071	CcSEcCtD
Nabilone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000616	0.000708	CcSEcCtD
Nabilone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000613	0.000706	CcSEcCtD
Nabilone—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000609	0.0007	CcSEcCtD
Nabilone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000608	0.0007	CcSEcCtD
Nabilone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000607	0.000698	CcSEcCtD
Nabilone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000603	0.000694	CcSEcCtD
Nabilone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000602	0.000693	CcSEcCtD
Nabilone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000597	0.000687	CcSEcCtD
Nabilone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000597	0.000687	CcSEcCtD
Nabilone—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000683	CcSEcCtD
Nabilone—Pain—Etoposide—peripheral nervous system neoplasm	0.000592	0.000681	CcSEcCtD
Nabilone—Constipation—Etoposide—peripheral nervous system neoplasm	0.000592	0.000681	CcSEcCtD
Nabilone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000587	0.000675	CcSEcCtD
Nabilone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000585	0.000673	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000584	0.00487	CbGpPWpGaD
Nabilone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.000671	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000582	0.00485	CbGpPWpGaD
Nabilone—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000576	0.000663	CcSEcCtD
Nabilone—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000574	0.00066	CcSEcCtD
Nabilone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000571	0.000657	CcSEcCtD
Nabilone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000568	0.000654	CcSEcCtD
Nabilone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000566	0.000651	CcSEcCtD
Nabilone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000565	0.00065	CcSEcCtD
Nabilone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000564	0.000649	CcSEcCtD
Nabilone—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000648	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000562	0.00469	CbGpPWpGaD
Nabilone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000559	0.000644	CcSEcCtD
Nabilone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000559	0.000643	CcSEcCtD
Nabilone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000557	0.000641	CcSEcCtD
Nabilone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000556	0.000639	CcSEcCtD
Nabilone—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000632	CcSEcCtD
Nabilone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000547	0.00063	CcSEcCtD
Nabilone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000547	0.00063	CcSEcCtD
Nabilone—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000544	0.000625	CcSEcCtD
Nabilone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000543	0.000625	CcSEcCtD
Nabilone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000542	0.000624	CcSEcCtD
Nabilone—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000542	0.000624	CcSEcCtD
Nabilone—Rash—Vincristine—peripheral nervous system neoplasm	0.000539	0.00062	CcSEcCtD
Nabilone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000538	0.00062	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000537	0.00448	CbGpPWpGaD
Nabilone—Headache—Vincristine—peripheral nervous system neoplasm	0.000535	0.000616	CcSEcCtD
Nabilone—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000531	0.000611	CcSEcCtD
Nabilone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000527	0.000606	CcSEcCtD
Nabilone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000526	0.000606	CcSEcCtD
Nabilone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000517	0.000595	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000514	0.00429	CbGpPWpGaD
Nabilone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000511	0.000587	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00051	0.00426	CbGpPWpGaD
Nabilone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00051	0.000587	CcSEcCtD
Nabilone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000509	0.000586	CcSEcCtD
Nabilone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000508	0.000584	CcSEcCtD
Nabilone—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000507	0.000583	CcSEcCtD
Nabilone—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000503	0.000579	CcSEcCtD
Nabilone—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000502	0.000577	CcSEcCtD
Nabilone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000497	0.000572	CcSEcCtD
Nabilone—Chills—Epirubicin—peripheral nervous system neoplasm	0.00049	0.000564	CcSEcCtD
Nabilone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00049	0.000564	CcSEcCtD
Nabilone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000488	0.000562	CcSEcCtD
Nabilone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000487	0.00056	CcSEcCtD
Nabilone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000481	0.000553	CcSEcCtD
Nabilone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000477	0.000548	CcSEcCtD
Nabilone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000476	0.000548	CcSEcCtD
Nabilone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000474	0.000545	CcSEcCtD
Nabilone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.000544	CcSEcCtD
Nabilone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.000542	CcSEcCtD
Nabilone—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.00054	CcSEcCtD
Nabilone—Tension—Epirubicin—peripheral nervous system neoplasm	0.000467	0.000537	CcSEcCtD
Nabilone—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000462	0.000531	CcSEcCtD
Nabilone—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00046	0.000529	CcSEcCtD
Nabilone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000458	0.000527	CcSEcCtD
Nabilone—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000454	0.000522	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000452	0.00377	CbGpPWpGaD
Nabilone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.00052	CcSEcCtD
Nabilone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000449	0.000517	CcSEcCtD
Nabilone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000516	CcSEcCtD
Nabilone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000441	0.000508	CcSEcCtD
Nabilone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00044	0.000507	CcSEcCtD
Nabilone—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00044	0.000506	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000439	0.00367	CbGpPWpGaD
Nabilone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000437	0.000503	CcSEcCtD
Nabilone—Rash—Etoposide—peripheral nervous system neoplasm	0.000437	0.000502	CcSEcCtD
Nabilone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000436	0.000502	CcSEcCtD
Nabilone—Headache—Etoposide—peripheral nervous system neoplasm	0.000434	0.000499	CcSEcCtD
Nabilone—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000497	CcSEcCtD
Nabilone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000429	0.000493	CcSEcCtD
Nabilone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000492	CcSEcCtD
Nabilone—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000427	0.000492	CcSEcCtD
Nabilone—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000491	CcSEcCtD
Nabilone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000426	0.00049	CcSEcCtD
Nabilone—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.00049	CcSEcCtD
Nabilone—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00042	0.000484	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000419	0.00349	CbGpPWpGaD
Nabilone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000481	CcSEcCtD
Nabilone—Cough—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000477	CcSEcCtD
Nabilone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000477	CcSEcCtD
Nabilone—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000412	0.000474	CcSEcCtD
Nabilone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000411	0.000473	CcSEcCtD
Nabilone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000411	0.000472	CcSEcCtD
Nabilone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.00047	CcSEcCtD
Nabilone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000468	CcSEcCtD
Nabilone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000466	CcSEcCtD
Nabilone—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000466	CcSEcCtD
Nabilone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000466	CcSEcCtD
Nabilone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000465	CcSEcCtD
Nabilone—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000464	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000403	0.00336	CbGpPWpGaD
Nabilone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.0004	0.00046	CcSEcCtD
Nabilone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000397	0.000457	CcSEcCtD
Nabilone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000456	CcSEcCtD
Nabilone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000455	CcSEcCtD
Nabilone—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000454	CcSEcCtD
Nabilone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000453	CcSEcCtD
Nabilone—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000391	0.00045	CcSEcCtD
Nabilone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000447	CcSEcCtD
Nabilone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000445	CcSEcCtD
Nabilone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000444	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000384	0.00321	CbGpPWpGaD
Nabilone—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.000442	CcSEcCtD
Nabilone—Shock—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000439	CcSEcCtD
Nabilone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.000439	CcSEcCtD
Nabilone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000437	CcSEcCtD
Nabilone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000436	CcSEcCtD
Nabilone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000375	0.000432	CcSEcCtD
Nabilone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000431	CcSEcCtD
Nabilone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000431	CcSEcCtD
Nabilone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000431	CcSEcCtD
Nabilone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.00043	CcSEcCtD
Nabilone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000426	CcSEcCtD
Nabilone—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000426	CcSEcCtD
Nabilone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000422	CcSEcCtD
Nabilone—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000417	CcSEcCtD
Nabilone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000417	CcSEcCtD
Nabilone—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000411	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000355	0.00296	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000354	0.000407	CcSEcCtD
Nabilone—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000407	CcSEcCtD
Nabilone—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000404	CcSEcCtD
Nabilone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000403	CcSEcCtD
Nabilone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000401	CcSEcCtD
Nabilone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000399	CcSEcCtD
Nabilone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000398	CcSEcCtD
Nabilone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000397	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000345	0.00288	CbGpPWpGaD
Nabilone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000394	CcSEcCtD
Nabilone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000393	CcSEcCtD
Nabilone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000388	CcSEcCtD
Nabilone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000386	CcSEcCtD
Nabilone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000385	CcSEcCtD
Nabilone—Pain—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000382	CcSEcCtD
Nabilone—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000382	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000329	0.00274	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000376	CcSEcCtD
Nabilone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000374	CcSEcCtD
Nabilone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000371	CcSEcCtD
Nabilone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000368	CcSEcCtD
Nabilone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000368	CcSEcCtD
Nabilone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000367	CcSEcCtD
Nabilone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000365	CcSEcCtD
Nabilone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000364	CcSEcCtD
Nabilone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000359	CcSEcCtD
Nabilone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000356	CcSEcCtD
Nabilone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000353	CcSEcCtD
Nabilone—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000353	CcSEcCtD
Nabilone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000353	CcSEcCtD
Nabilone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000353	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000302	0.00252	CbGpPWpGaD
Nabilone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000341	CcSEcCtD
Nabilone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000338	CcSEcCtD
Nabilone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000329	CcSEcCtD
Nabilone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000327	CcSEcCtD
Nabilone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000327	CcSEcCtD
Nabilone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000278	0.00032	CcSEcCtD
Nabilone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000316	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000272	0.00227	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000267	0.00223	CbGpPWpGaD
Nabilone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000306	CcSEcCtD
Nabilone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000304	CcSEcCtD
Nabilone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000296	CcSEcCtD
Nabilone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000295	CcSEcCtD
Nabilone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000292	CcSEcCtD
Nabilone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000284	CcSEcCtD
Nabilone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000283	CcSEcCtD
Nabilone—Rash—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000282	CcSEcCtD
Nabilone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000281	CcSEcCtD
Nabilone—Headache—Epirubicin—peripheral nervous system neoplasm	0.000243	0.00028	CcSEcCtD
Nabilone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000273	CcSEcCtD
Nabilone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000265	CcSEcCtD
Nabilone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000263	CcSEcCtD
Nabilone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000261	CcSEcCtD
Nabilone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.00026	CcSEcCtD
Nabilone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000259	CcSEcCtD
Nabilone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000245	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000213	0.00178	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000211	0.00176	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00021	0.00175	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000199	0.00166	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000193	0.00161	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000192	0.0016	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000176	0.00146	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000166	0.00138	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000161	0.00134	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000156	0.0013	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000152	0.00127	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.00015	0.00125	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.00015	0.00125	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000138	0.00115	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000126	0.00105	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000123	0.00102	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000117	0.00098	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000117	0.000979	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000104	0.000865	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.64e-05	0.000804	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.22e-05	0.000769	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.14e-05	0.000679	CbGpPWpGaD
